Teva Finds Relief In US Opioid Crisis Settlement, Updates Long-Term Objectives
Will Pay Up To $4.25bn To Close Opioid Chapter
Executive Summary
The Israeli firm announced a US-wide settlement for opioid crisis litigation that has been hanging over it for years, as forex took its toll on its second-quarter revenues.
You may also be interested in...
Teva's New CEO Francis Takes Over A Steadier – Though Still Rocky – Organization
Teva announced the appointment of former Sandoz CEO Richard Francis as its next leader as Kare Schultz steps down.
Teva Agrees $931,000 For Arkansas To Dismiss Price-Fixing Claims
Teva will pay $931, 000 to dismiss price-fixing claims filed in a 2020 multistate lawsuit but its legal troubles are far from over.
Teva Settles With San Francisco But New York Could Be Set To Prize Open Old Wounds
Teva has settled the final outstanding advanced US state-level opioid-related case against the firm, but recent allegations from the New York attorney general could see the firm back in court sooner rather than later.